Dementia-Alzheimer’s Research Papers~ April 2000

Dementia-Alzheimer’s Research Papers~ April 2000    

           

Doll R, Peto R, Boreham J, Sutherland I. Smoking and dementia in male British doctors: prospective study. BMJ. 2000 Apr 22;320(7242):1097-102.

Marcos T, Salamero M, de Azpiazu P, Pujol J, Boget T, Peri JM, Lázaro ML. [Neuropsychological pattern of cognitive impairment in Alzheimer type dementia and vascular dementia] Med Clin (Barc). 2000 Apr 22;114(15):566-70.

Giovanni A, Keramaris E, Morris EJ, Hou ST, O'Hare M, Dyson N, Robertson GS, Slack RS, Park DS. E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3. J Biol Chem. 2000 Apr 21;275(16):11553-60.

 

Zill P, Padberg F, de Jonge S, Hampel H, Bürger K, Stübner S, Boetsch T, Jürgen Möller H, Ackenheil M, Bondy B. Serotonin transporter (5-HTT) gene polymorphism in psychogeriatric patients. Neurosci Lett. 2000 Apr 21;284(1-2):113-5. , ,

Riemenschneider M, Schmolke M, Lautenschlager N, Guder WG, Vanderstichele H, Vanmechelen E, Kurz A. Cerebrospinal beta-amyloid ((1-42)) in early Alzheimer's disease: association with apolipoprotein E genotype and cognitive decline. Neurosci Lett. 2000 Apr 21;284(1-2):85-8. ,

Kwon JM, Nowotny P, Shah PK, Chakraverty S, Norton J, Morris JC, Goate AM. Tau polymorphisms are not associated with Alzheimer's disease. Neurosci Lett. 2000 Apr 21;284(1-2):77-80. , ,

Hegedus ZL. The probable involvement of soluble and deposited melanins, their intermediates and the reactive oxygen side-products in human diseases and aging. Toxicology. 2000 Apr 14;145(2-3):85-101.

Heutink P. Untangling tau-related dementia. Hum Mol Genet. 2000 Apr 12;9(6):979-86.

Culetto E, Sattelle DB. A role for Caenorhabditis elegans in understanding the function and interactions of human disease genes. Hum Mol Genet. 2000 Apr 12;9(6):869-77.

Kahle PJ, Jakowec M, Teipel SJ, Hampel H, Petzinger GM, Di Monte DA, Silverberg GD, Möller HJ, Yesavage JA, Tinklenberg JR, Shooter EM, Murphy GM. Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF. Neurology. 2000 Apr 11;54(7):1498-504. ,

Chang BD, Watanabe K, Broude EV, Fang J, Poole JC, Kalinichenko TV, Roninson IB. Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4291-6.

Cohen VI, Jin B, McRee RC, Boulay SF, Cohen EI, Sood VK, Zeeberg BR, Reba RC. In vitro and in vivo m2 muscarinic subtype selectivity of some dibenzodiazepinones and pyridobenzodiazepinones. Brain Res. 2000 Apr 10;861(2):305-15.

Bagli M, Papassotiropoulos A, Knapp M, Jessen F, Luise Rao M, Maier W, Heun R. Association between an interleukin-6 promoter and 3' flanking region haplotype and reduced Alzheimer's disease risk in a German population. Neurosci Lett. 2000 Apr 7;283(2):109-12. ,

Leuba G, Saini K, Savioz A, Charnay Y. Early-onset familial Alzheimer disease with coexisting beta-amyloid and prion pathology. JAMA. 2000 Apr 5;283(13):1689-91.

Mooser V, Helbecque N, Miklossy J, Marcovina SM, Nicod P, Amouyel P. Interactions between apolipoprotein E and apolipoprotein(a) in patients with late-onset Alzheimer disease. Ann Intern Med. 2000 Apr 4;132(7):533-7. ,

Tang G, Jiang S, Zhang M, Lin S, Qian Y, Wu X, Wang D, Jin T, Gu N. Genetic association study between alpha 1-antichymotrypsin polymorphism and Alzheimer disease in Chinese Han population. Am J Med Genet. 2000 Apr 3;96(2):133-5. ,

Lee DW, Liu HC, Liu TY, Chi CW, Hong CJ. No association between butyrylcholinesterase K-variant and Alzheimer disease in Chinese. Am J Med Genet. 2000 Apr 3;96(2):167-9. ,

Hauber AB, Gnanasakthy A, Snyder EH, Bala MV, Richter A, Mauskopf JA. Potential savings in the cost of caring for Alzheimer's disease. Treatment with rivastigmine. Pharmacoeconomics. 2000 Apr;17(4):351-60.

Hiltunen M, Helisalmi S, Mannermaa A, Alafuzoff I, Koivisto AM, Lehtovirta M, Pirskanen M, Sulkava R, Verkkoniemi A, Soininen H. Identification of a novel 4.6-kb genomic deletion in presenilin-1 gene which results in exclusion of exon 9 in a Finnish early onset Alzheimer's disease family: an Alu core sequence-stimulated recombination? Eur J Hum Genet. 2000 Apr;8(4):259-66.

Kálmán J, Márki-Zay J, Juhász A, Sántha A, Dux L, Janka Z. Serum and cerebrospinal fluid cystatin C levels in vascular and Alzheimer's dementia. Acta Neurol Scand. 2000 Apr 1;101(4):279-82. ,

Schellenberg GD, D'Souza I, Poorkaj P. The genetics of Alzheimer's disease. Curr Psychiatry Rep. 2000 Apr;2(2):158-64.

Freeborne N. Alzheimer's disease: the possibility of prevention and early treatment. JAAPA. 2000 Apr;13(4):32-4, 37-8.

Meijer L. Cyclin-dependent kinases inhibitors as potential anticancer, antineurodegenerative, antiviral and antiparasitic agents. Drug Resist Updat. 2000 Apr;3(2):83-88.

Pedersen WA, Chan SL, Mattson MP. A mechanism for the neuroprotective effect of apolipoprotein E: isoform-specific modification by the lipid peroxidation product 4-hydroxynonenal. J Neurochem. 2000 Apr;74(4):1426-33.

Barrow PA, Empson RM, Gladwell SJ, Anderson CM, Killick R, Yu X, Jefferys JG, Duff K. Functional phenotype in transgenic mice expressing mutant human presenilin-1. Neurobiol Dis. 2000 Apr;7(2):119-26.

Capell A, Steiner H, Romig H, Keck S, Baader M, Grim MG, Baumeister R, Haass C. Presenilin-1 differentially facilitates endoproteolysis of the beta-amyloid precursor protein and Notch. Nat Cell Biol. 2000 Apr;2(4):205-11.

Lu DC, Rabizadeh S, Chandra S, Shayya RF, Ellerby LM, Ye X, Salvesen GS, Koo EH, Bredesen DE. A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor. Nat Med. 2000 Apr 1;6(4):397-404.

 

Reynolds CH, Betts JC, Blackstock WP, Nebreda AR, Anderton BH. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta. J Neurochem. 2000 Apr;74(4):1587-95.

Beach TG, Kuo YM, Spiegel K, Emmerling MR, Sue LI, Kokjohn K, Roher AE. The cholinergic deficit coincides with Abeta deposition at the earliest histopathologic stages of Alzheimer disease. J Neuropathol Exp Neurol. 2000 Apr 1;59(4):308-13.

    

Dahl C, Haug LS, Spilsberg B, Johansen J, Ostvold AC, Diemer NH. Reduced [3H]IP3 binding but unchanged IP3 receptor levels in the rat hippocampus CA1 region following transient global ischemia and tolerance induction. Neurochem Int. 2000 Apr;36(4-5):379-88.

Berendse HW, Verbunt JP, Scheltens P, van Dijk BW, Jonkman EJ. Magnetoencephalographic analysis of cortical activity in Alzheimer's disease: a pilot study. Clin Neurophysiol. 2000 Apr;111(4):604-12.

Hu Q, Jin LW, Starbuck MY, Martin GM. Broadly altered expression of the mRNA isoforms of FE65, a facilitator of beta amyloidogenesis, in Alzheimer cerebellum and other brain regions. J Neurosci Res. 2000 Apr 1;60(1):73-86.

Chen QS, Kagan BL, Hirakura Y, Xie CW. Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides. J Neurosci Res. 2000 Apr 1;60(1):65-72.

Robinson SR. Neuronal expression of glutamine synthetase in Alzheimer's disease indicates a profound impairment of metabolic interactions with astrocytes. Neurochem Int. 2000 Apr;36(4-5):471-82.

Hösli E, Hösli L. Colocalization of neurotransmitter receptors on astrocytes in explant cultures of rat CNS. Neurochem Int. 2000 Apr;36(4-5):301-11.

  

Snowdon DA, Tully CL, Smith CD, Riley KP, Markesbery WR. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study. Am J Clin Nutr. 2000 Apr;71(4):993-8. ,

 

Thöny B, Auerbach G, Blau N. Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J. 2000 Apr 1;347 Pt 1:1-16.

Hall GF, Chu B, Lee G, Yao J. Human tau filaments induce microtubule and synapse loss in an in vivo model of neurofibrillary degenerative disease. J Cell Sci. 2000 Apr;113 ( Pt 8):1373-87.

Salinero O, Moreno-Flores MT, Wandosell F. Increasing neurite outgrowth capacity of beta-amyloid precursor protein proteoglycan in Alzheimer's disease. J Neurosci Res. 2000 Apr 1;60(1):87-97.

Campbell A, Kumar A, La Rosa FG, Prasad KN, Bondy SC. Aluminum increases levels of beta-amyloid and ubiquitin in neuroblastoma but not in glioma cells. Proc Soc Exp Biol Med. 2000 Apr;223(4):397-402.

Bowen RL, Isley JP, Atkinson RL. An association of elevated serum gonadotropin concentrations and Alzheimer disease? J Neuroendocrinol. 2000 Apr 1;12(4):351-4.

Cui T, Zhou X, Jin W, Zheng F, Cao X. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease. Chin Med J (Engl). 2000 Apr;113(4):340-4. ,

Gupta M, Kulkarni SK. Studies on anticonvulsant actions of L-deprenyl. Indian J Exp Biol. 2000 Apr;38(4):332-7.

Grilly DM, Simon BB, Levin ED. Nicotine enhances stimulus detection performance of middle- and old-aged rats: a longitudinal study. Pharmacol Biochem Behav. 2000 Apr;65(4):665-70.

Robertson GS, Crocker SJ, Nicholson DW, Schulz JB. Neuroprotection by the inhibition of apoptosis. Brain Pathol. 2000 Apr;10(2):283-92.

Askanas V, Engel WK, Alvarez RB, Frangione B, Ghiso J, Vidal R. Inclusion body myositis, muscle blood vessel and cardiac amyloidosis, and transthyretin Val122Ile allele. Ann Neurol. 2000 Apr;47(4):544-9.

Aoyama K, Matsubara K, Fujikawa Y, Nagahiro Y, Shimizu K, Umegae N, Hayase N, Shiono H, Kobayashi S. Nitration of manganese superoxide dismutase in cerebrospinal fluids is a marker for peroxynitrite-mediated oxidative stress in neurodegenerative diseases. Ann Neurol. 2000 Apr;47(4):524-7.

Pihlajamäki M, Tanila H, Hänninen T, Könönen M, Laakso M, Partanen K, Soininen H, Aronen HJ. Verbal fluency activates the left medial temporal lobe: a functional magnetic resonance imaging study. Ann Neurol. 2000 Apr;47(4):470-6.

  

Killiany RJ, Gomez-Isla T, Moss M, Kikinis R, Sandor T, Jolesz F, Tanzi R, Jones K, Hyman BT, Albert MS. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol. 2000 Apr;47(4):430-9.

McCaddon A, Davies G, Hudson P. Nutritionally independent B12 deficiency and Alzheimer disease. Arch Neurol. 2000 Apr;57(4):607-8.

Mori E, Shimomura T, Fujimori M, Hirono N, Imamura T, Hashimoto M, Tanimukai S, Kazui H, Hanihara T. Visuoperceptual impairment in dementia with Lewy bodies. Arch Neurol. 2000 Apr;57(4):489-93.

Ezquerra M, Carnero C, Blesa R, Oliva R. A novel presenilin 1 mutation (Leu166Arg) associated with early-onset Alzheimer disease. Arch Neurol. 2000 Apr;57(4):485-8.

Emilien G, Beyreuther K, Masters CL, Maloteaux JM. Prospects for pharmacological intervention in Alzheimer disease. Arch Neurol. 2000 Apr;57(4):454-9.

Phelps ME. PET: the merging of biology and imaging into molecular imaging. J Nucl Med. 2000 Apr;41(4):661-81.

Pietrini P, Alexander GE, Furey ML, Dani A, Mentis MJ, Horwitz B, Guazzelli M, Shapiro MB, Rapoport SI. Cerebral metabolic response to passive audiovisual stimulation in patients with Alzheimer's disease and healthy volunteers assessed by PET. J Nucl Med. 2000 Apr;41(4):575-83.

Maki N, Ikeda M, Hokoishi K, Nomura M, Torikawa S, Fujimoto N, Komori K, Hirono N, Tanabe H. Interrater reliability of the short-memory questionnaire in a variety of health professional representatives. Int J Geriatr Psychiatry. 2000 Apr;15(4):373-5.

Visser PJ, Verhey FR, Ponds RW, Cruts M, Van Broeckhoven CL, Jolles J. Course of objective memory impairment in non-demented subjects attending a memory clinic and predictors of outcome. Int J Geriatr Psychiatry. 2000 Apr;15(4):363-72.

Elad P, Treves TA, Drory M, Verchovsky R, Klimovitsky S, Ben-Laish S, Yaron S, Ginzburg K, Korczyn AD. Demented patients' participation in a clinical trial: factors affecting the caregivers' decision. Int J Geriatr Psychiatry. 2000 Apr;15(4):325-30.

Denihan A, Wilson G, Cunningham C, Coakley D, Lawlor BA. CT measurement of medial temporal lobe atrophy in Alzheimer's disease, vascular dementia, depression and paraphrenia. Int J Geriatr Psychiatry. 2000 Apr;15(4):306-12.

Passafiume D, Di Giacomo D, Giubilei F. Reading latency of words and nonwords in Alzheimer's patients. Cortex. 2000 Apr;36(2):293-8.

Nakamura H, Nakanishi M, Hamanaka T, Nakaaki S, Yoshida S. Semantic priming in patients with Alzheimer and semantic dementia. Cortex. 2000 Apr;36(2):151-62.

Yanagisawa K. Neuronal death in Alzheimer's disease. Intern Med. 2000 Apr;39(4):328-30.

Harwood DG, Sultzer DL, Wheatley MV. Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances. Neuropsychiatry Neuropsychol Behav Neurol. 2000 Apr;13(2):83-8.

Chollet DF, Castella E, Anderegg G, Arnera V, Hadler D. Therapeutic drug monitoring of tacrine: simple and fast high-performance liquid chromatography assay method for its determination in human plasma. Ther Drug Monit. 2000 Apr;22(2):225-9.

Yamanishi Y, Ogura H, Kosasa T. [Development of donepezil hydrochloride (Aricept) for the treatment of Alzheimer's disease] Tanpakushitsu Kakusan Koso. 2000 Apr;45(6 Suppl):1047-51.

Han SH, Chung SY. Marked hippocampal neuronal damage without motor deficits after mild concussive-like brain injury in apolipoprotein E-deficient mice. Ann N Y Acad Sci. 2000 Apr;903:357-65.

Rhodin J, Thomas T, Bryant M, Sutton ET. Animal model of Alzheimer-like vascular pathology and inflammatory reaction. Ann N Y Acad Sci. 2000 Apr;903:345-52.

Sparks DL, Kuo YM, Roher A, Martin T, Lukas RJ. Alterations of Alzheimer's disease in the cholesterol-fed rabbit, including vascular inflammation. Preliminary observations. Ann N Y Acad Sci. 2000 Apr;903:335-44.

Pluta R. The role of apolipoprotein E in the deposition of beta-amyloid peptide during ischemia-reperfusion brain injury. A model of early Alzheimer's disease. Ann N Y Acad Sci. 2000 Apr;903:324-34.

Wyss-Coray T, Lin C, von Euw D, Masliah E, Mucke L, Lacombe P. Alzheimer's disease-like cerebrovascular pathology in transforming growth factor-beta 1 transgenic mice and functional metabolic correlates. Ann N Y Acad Sci. 2000 Apr;903:317-23.

Burgermeister P, Calhoun ME, Winkler DT, Jucker M. Mechanisms of cerebrovascular amyloid deposition. Lessons from mouse models. Ann N Y Acad Sci. 2000 Apr;903:307-16.

Viitanen M, Kalimo H. CADASIL: hereditary arteriopathy leading to multiple brain infarcts and dementia. Ann N Y Acad Sci. 2000 Apr;903:273-84.

Nagata K, Maruya H, Yuya H, Terashi H, Mito Y, Kato H, Sato M, Satoh Y, Watahiki Y, Hirata Y, Yokoyama E, Hatazawa J. Can PET data differentiate Alzheimer's disease from vascular dementia? Ann N Y Acad Sci. 2000 Apr;903:252-61.

Alafuzoff I, Helisalmi S, Mannermaa A, Soininen H. Severity of cardiovascular disease, apolipoprotein E genotype, and brain pathology in aging and dementia. Ann N Y Acad Sci. 2000 Apr;903:244-51.

Esiri MM. Which vascular lesions are of importance in vascular dementia? Ann N Y Acad Sci. 2000 Apr;903:239-43.

Emery VO, Gillie EX, Smith JA. Interface between vascular dementia and Alzheimer syndrome. Nosologic redefinition. Ann N Y Acad Sci. 2000 Apr;903:229-38.

Craft S, Asthana S, Schellenberg G, Baker L, Cherrier M, Boyt AA, Martins RN, Raskind M, Peskind E, Plymate S. Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype. Ann N Y Acad Sci. 2000 Apr;903:222-8.

Blass JP, Sheu RK, Gibson GE. Inherent abnormalities in energy metabolism in Alzheimer disease. Interaction with cerebrovascular compromise. Ann N Y Acad Sci. 2000 Apr 1;903:204-21.

van Rensburg SJ, Potocnik FC, De Villiers JN, Kotze MJ, Taljaard JJ. Earlier age of onset of Alzheimer's disease in patients with both the transferrin C2 and apolipoprotein E-epsilon 4 alleles. Ann N Y Acad Sci. 2000 Apr;903:200-3. ,

Verbeek MM, Van Nostrand WE, Otte-Höller I, Wesseling P, de Waal RM. Amyloid-beta-induced degeneration of human brain pericytes is dependent on the apolipoprotein E genotype. Ann N Y Acad Sci. 2000 Apr;903:187-99.

Prior R, Wihl G, Urmoneit B. Apolipoprotein E, smooth muscle cells and the pathogenesis of cerebral amyloid angiopathy: the potential role of impaired cerebrovascular A beta clearance. Ann N Y Acad Sci. 2000 Apr;903:180-6.

McCarron MO, Nicoll JA. Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage. Ann N Y Acad Sci. 2000 Apr;903:176-9.

Suo Z, Su G, Placzek A, Kundtz A, Humphrey J, Crawford F, Mullan M. A beta vasoactivity in vivo. Ann N Y Acad Sci. 2000 Apr;903:156-63.

Olichney JM, Hansen LA, Lee JH, Hofstetter CR, Katzman R, Thal LJ. Relationship between severe amyloid angiopathy, apolipoprotein E genotype, and vascular lesions in Alzheimer's disease. Ann N Y Acad Sci. 2000 Apr;903:138-43.

Friedland RP, Shi J, Lamanna JC, Smith MA, Perry G. Prospects for noninvasive imaging of brain amyloid beta in Alzheimer's disease. Ann N Y Acad Sci. 2000 Apr;903:123-8.

Emmerling MR, Morganti-Kossmann MC, Kossmann T, Stahel PF, Watson MD, Evans LM, Mehta PD, Spiegel K, Kuo YM, Roher AE, Raby CA. Traumatic brain injury elevates the Alzheimer's amyloid peptide A beta 42 in human CSF. A possible role for nerve cell injury. Ann N Y Acad Sci. 2000 Apr;903:118-22.

Weller RO, Massey A, Kuo YM, Roher AE. Cerebral amyloid angiopathy: accumulation of A beta in interstitial fluid drainage pathways in Alzheimer's disease. Ann N Y Acad Sci. 2000 Apr 1;903:110-7.

Van Nostrand WE, Melchor J, Wagner M, Davis J. Cerebrovascular smooth muscle cell surface fibrillar A beta. Alteration of the proteolytic environment in the cerebral vessel wall. Ann N Y Acad Sci. 2000 Apr;903:89-96.

Thomas AJ, Morris CM, Ferrier IN, Kalaria RN. Distribution of amyloid beta 42 in relation to the cerebral microvasculature in an elderly cohort with Alzheimer's disease. Ann N Y Acad Sci. 2000 Apr;903:83-8.

Farkas E, De Jong GI, Apró E, de Vos RA, Steur EN, Luiten PG. Similar ultrastructural breakdown of cerebrocortical capillaries in Alzheimer's disease, Parkinson's disease, and experimental hypertension. What is the functional link? Ann N Y Acad Sci. 2000 Apr;903:72-82.

Grammas P, Reimann-Philipp U, Weigel PH. Cerebrovasculature-mediated neuronal cell death. Ann N Y Acad Sci. 2000 Apr;903:55-60.

Miyakawa T, Kimura T, Hirata S, Fujise N, Ono T, Ishizuka K, Nakabayashi J. Role of blood vessels in producing pathological changes in the brain with Alzheimer's disease. Ann N Y Acad Sci. 2000 Apr;903:46-54.

Brown WR, Moody DM, Thore CR, Challa VR. Cerebrovascular pathology in Alzheimer's disease and leukoaraiosis. Ann N Y Acad Sci. 2000 Apr;903:39-45.

Snowdon DA, Greiner LH, Markesbery WR. Linguistic ability in early life and the neuropathology of Alzheimer's disease and cerebrovascular disease. Findings from the Nun Study. Ann N Y Acad Sci. 2000 Apr;903:34-8.

Schubert P, Morino T, Miyazaki H, Ogata T, Nakamura Y, Marchini C, Ferroni S. Cascading glia reactions: a common pathomechanism and its differentiated control by cyclic nucleotide signaling. Ann N Y Acad Sci. 2000 Apr;903:24-33.

Wisniewski HM, Wegiel J, Vorbrodt AW, Mazur-Kolecka B, Frackowiak J. Role of perivascular cells and myocytes in vascular amyloidosis. Ann N Y Acad Sci. 2000 Apr;903:6-18.

Scheltens P, Kittner B. Preliminary results from an MRI/CT-based database for vascular dementia and Alzheimer's disease. Ann N Y Acad Sci. 2000 Apr;903:542-6.

Ringheim GE. Glial modulating and neurotrophic properties of propentofylline and its application to Alzheimer's disease and vascular dementia. Ann N Y Acad Sci. 2000 Apr;903:529-34.

Rockwood K, MacKnight C, Wentzel C, Black S, Bouchard R, Gauthier S, Feldman H, Hogan D, Kertesz A, Montgomery P. The diagnosis of "mixed" dementia in the Consortium for the Investigation of Vascular Impairment of Cognition (CIVIC). Ann N Y Acad Sci. 2000 Apr;903:522-8.

Thomas T, Rhodin J. Vascular actions of estrogen and Alzheimer's disease. Ann N Y Acad Sci. 2000 Apr;903:501-9.

O'Brien J, Perry R, Barber R, Gholkar A, Thomas A. The association between white matter lesions on magnetic resonance imaging and noncognitive symptoms. Ann N Y Acad Sci. 2000 Apr;903:482-9.

Hampel H, Teipel SJ, Alexander GE, Horwitz B, Pietrini P, Hippius H, Möller HJ, Schapiro MB, Rapoport SI. Corpus callosum measurement as an in vivo indicator for neocortical neuronal integrity, but not white matter pathology, in Alzheimer's disease. Ann N Y Acad Sci. 2000 Apr;903:470-6.

Pasquier F, Hénon H, Leys D. Relevance of white matter changes to pre- and poststroke dementia. Ann N Y Acad Sci. 2000 Apr;903:466-9.

Ballard C, O'Brien J, Barber B, Scheltens P, Shaw F, McKeith I, Kenny RA. Neurocardiovascular instability, hypotensive episodes, and MRI lesions in neurodegenerative dementia. Ann N Y Acad Sci. 2000 Apr;903:442-5.

Amouyel P, Richard F, Berr C, David-Fromentin I, Helbecque N. The renin angiotensin system and Alzheimer's disease. Ann N Y Acad Sci. 2000 Apr;903:437-41.